Search hospitals > Texas > Dallas
University of Texas Southwestern Medical Center
Claim this profileDallas, Texas 75390
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Depression
Conducts research for Heart Failure
2260 reported clinical trials
223 medical researchers
Summary
University of Texas Southwestern Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Depression, Heart Failure and other specialties. University of Texas Southwestern Medical Center is involved with conducting 2,260 clinical trials across 2,047 conditions. There are 223 research doctors associated with this hospital, such as David Miller, MD, Matthew Campbell, MD, Syed M. Kazmi, and Patrick Leavey, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
2Lung Cancer
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
David Miller, MDParkland Memorial Hospital3 years of reported clinical research
Studies Ovarian Cancer
Studies Cervical Cancer
21 reported clinical trials
40 drugs studied
Matthew Campbell, MDUT Southwestern/Simmons Cancer Center-Dallas3 years of reported clinical research
Studies Bladder Cancer
Studies Rhabdomyosarcoma
19 reported clinical trials
36 drugs studied
Syed M. KazmiUT Southwestern/Simmons Cancer Center-Dallas8 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
17 reported clinical trials
33 drugs studied
Patrick Leavey, MDUT Southwestern/Simmons Cancer Center-Dallas4 years of reported clinical research
Studies Cancer
Studies Soft Tissue Sarcoma
16 reported clinical trials
34 drugs studied
Clinical Trials running at University of Texas Southwestern Medical Center
Breast Cancer
Prostate Cancer
Colorectal Cancer
Kidney Cancer
Spinal Muscular Atrophy
Cystic Fibrosis
Chronic Lymphocytic Leukemia
Hemophilia A
Cancer
Glaucoma
Endocrine + CDK4/6 Inhibitor Therapy
for Breast Cancer
This trial is studying if hormone therapy and a drug that stops cell growth can improve the immune system's response against hormone-sensitive breast cancer.
Recruiting3 awards Phase 213 criteria
Gadolinium-Based Contrast Media Effects on Motor and Cognitive Functioning
for undefined
This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth. In this study researchers want to find out whether so called gadolinium-based contrast agents (GBCAs) have an effect on body movement and mental skills when given to participants multiple times within 5 years. The study plans to enroll about 2076 participants suffering from a condition for which they are likely to have at least annually a MRI or another imaging examinations. Only adults up to 65 years will be considered to join this study. During the study duration of 5 years participants will receive annually a MRI or other imaging tests (such as CT-scan, x-ray) and will visit the study doctor at least 7 times for physical examinations, laboratory investigations and tests on body movement and mental skills.
Recruiting3 awards Phase 49 criteria
sac-TMT + Pembrolizumab
for Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery. The primary objective is to compare sacituzumab tirumotecan plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine) with respect to invasive disease-free survival (iDFS) per investigator assessment. It is hypothesized that sacituzumab tirumotecan plus pembrolizumab is superior to TPC with respect to iDFS per investigator assessment.
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Texas Southwestern Medical Center?
University of Texas Southwestern Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Depression, Heart Failure and other specialties. University of Texas Southwestern Medical Center is involved with conducting 2,260 clinical trials across 2,047 conditions. There are 223 research doctors associated with this hospital, such as David Miller, MD, Matthew Campbell, MD, Syed M. Kazmi, and Patrick Leavey, MD.
Where is University of Texas Southwestern Medical Center located?
The University of Texas Southwestern Medical Center is situated at 5323 Harry Hines Blvd, Dallas, Texas, United States. For access, use I-35E N, exit at Medical District Drive, and proceed west towards Harry Hines Blvd; the center is located on the left side.
Who should I call to ask about financial aid or insurance network?
**University of Texas Southwestern Medical Center - Financial Assistance and Contact Information**
- **Financial Assistance Department:** For assistance, call 469-291-2000 or toll-free at 866-648-2455, Monday through Friday, 8:00 a.m. to 5:00 p.m. Mail completed applications and required documentation to FinancialAssistance@UT Southwestern Medical Center (Mail Code 9233), P.O. Box 36423, Dallas, Texas 75235-9662.
- **Billing and Insurance Questions:** Contact the Account Resolutions Department at 469-291-2000 or toll-free at 866-648-2455, online via MyChart, or by mail at P.O. Box 848009, Dallas, TX 75284-8009.
- **General Information:** Call 214-648-3111 or write to UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390.
What insurance does University of Texas Southwestern Medical Center accept?
The University of Texas Southwestern Medical Center accepts a wide range of major medical insurance plans. These include, but are not limited to, Aetna, Blue Cross Blue Shield Texas, Humana, UnitedHealthcare, and Wellcare. For a detailed list of specific insurance plans accepted, particularly by UT Physicians, patients are advised to verify their coverage directly with the clinical practice or hospital.
What awards or recognition has University of Texas Southwestern Medical Center received?
The University of Texas Southwestern Medical Center, located in Dallas, Texas, is ranked as the #1 hospital in Texas (tie) and among the top 20 in the nation for 2023-24 by U.S. News & World Report, with 11 of its specialties recognized in the top 50 nationally. It has earned accolades for diversity and inclusion, being named a Top LGBTQ+ Friendly Company and a Top Healthcare Company by notable publications. The center's research programs, funded by approximately $554.4 million annually, have made significant contributions, including the development of statin drugs and the discovery of gene variants affecting LDL cholesterol levels in the Dallas Heart Study.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.